Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4+and CD8+T cells

(2017) Geoffrey A. Smith et al.   Science Signaling

IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4+and CD8+T cells

(2017) Geoffrey A. Smith et al.   Science Signaling

Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study

(2016) T. Yamamoto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells

(2016) Christian H. Gabriel et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience

(2016) Yoichiro Nuki et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis

(2016) Katsuya Endo et al.   Gastroenterology Research and Practice

Exploring the relationship between lifestyles, diets and genetic adaptations in humans

(2015) Cristina Valente et al.   BMC GENETICS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing

(2015) KA Birdwell et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis

(2015) Kentaro Ikeya et al.   DIGESTIVE AND LIVER DISEASE

Tu1366 Tacrolimus Therapy for Outpatients With Refractory Ulcerative Colitis

(2015) Sakiko Hiraoka et al.   GASTROENTEROLOGY

Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis

(2015) Yuga Komaki et al.   Journal of Crohns & Colitis

Mitogen-activated protein kinase cascades in signaling plant growth and development

(2015) Juan Xu et al.   TRENDS IN PLANT SCIENCE

Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis

(2015) Ken Kawakami   WORLD JOURNAL OF GASTROENTEROLOGY

Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment

(2014) Gilles Boschetti et al.   DIGESTIVE AND LIVER DISEASE

Oral Tacrolimus for the Treatment of Refractory Inflammatory Bowel Disease in the Biologic Era

(2013) Lena W. Y. Thin et al.   INFLAMMATORY BOWEL DISEASES

Oral tacrolimus as maintenance therapy for refractory ulcerative colitis—an analysis of outcomes in two London tertiary centres

(2013) Jonathan Landy et al.   Journal of Crohns & Colitis

Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients

(2013) Jun Miyoshi et al.   Journal of Crohns & Colitis

PharmGKB summary

(2013) Julia M. Barbarino et al.   Pharmacogenetics and Genomics

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

(2012) K. J. Schmidt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Inflammatory bowel disease pathogenesis

(2012) Michael Scharl et al.   CURRENT OPINION IN GASTROENTEROLOGY

First-Line Therapies in Inflammatory Bowel Disease

(2012) Marc Girardin et al.   DIGESTION

The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients

(2012) Salvatore Terrazzino et al.   Pharmacogenetics and Genomics

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

(2011) L. Elens et al.   CLINICAL CHEMISTRY

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

(2011) Haruhiko Ogata et al.   INFLAMMATORY BOWEL DISEASES

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

(2010) D Wang et al.   PHARMACOGENOMICS JOURNAL

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis

(2008) S. YAMAMOTO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohnʼs disease: A single-center experience

(2007) Aaron Benson et al.   INFLAMMATORY BOWEL DISEASES